 |
|
Evaluation of Youth Preferences for Rapid and Innovative Human Immunodeficiency Virus Antibody Tests
Ligia Peralta, MD;
Niel Constantine, PhD;
Bethany Griffin Deeds, MA;
Lee Martin, PhD;
Kareem Ghalib, BA
Arch Pediatr Adolesc Med. 2001;155:838-843.
Objective To determine youth preferences for Food and Drug Administration (FDA)-approved
and investigational human immunodeficiency virus (HIV) antibody collection
and testing methods before and after subjects learned of test result response
times; to determine how influential test result response times are on participants'
preferences.
Design After health educators explained and demonstrated 6 different HIV antibody
collection and testing strategies (3 saliva, 1 urine, and 2 fingerstick methods),
participants completed a confidential survey about test method preference
and tried the different testing methods. The participants had an opportunity
to re-rank their test method preference after learning about each test's result
response time.
Setting Health education sessions in both clinical and community settings.
Participants Youths aged 12 to 24 years.
Results An oral collection device with a rapid saliva test was the most highly
preferred test method. The preference for this method and the rapid response
test methods via fingerstick procedures improved significantly after subjects
learned of the rapid result response time, while the other methods were given
significantly lower preference rankings after subjects learned of the longer
result response times. Shifts in preference rankings were not related to sex,
age, ethnic group, experience with HIV testing, or practice of risk behaviors.
Conclusions Our research supports the use of noninvasive and rapid HIV testing methods
with rapid response times for adolescents to assist in the early identification
of HIV status, while offering HIV prevention opportunities and immediate linkage
to care.
From the Departments of Pediatrics (Drs Peralta and Martin, Ms Deeds,
and Mr Ghalib) and Pathology (Dr Constantine), University of Maryland School
of Medicine, Baltimore. The testing devices for this study were supplied by
the different manufacturers; however, this study was not funded by the manufacturers,
and the authors have no financial interest in these devices.
Corresponding author and reprints: Ligia Peralta, MD, University
of Maryland School of Medicine, Department of Pediatrics, Division of Adolescent
Medicine, 655 W Lombard St, Suite 311, Baltimore, MD 21201 (e-mail: lperalta{at}peds.umaryland.edu).
RELATED ARTICLE
Improving Human Immunodeficiency Virus Testing for Adolescents
Alain Joffe
Arch Pediatr Adolesc Med. 2001;155(7):761-762.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Improving Human Immunodeficiency Virus Testing for Adolescents
Joffe
Arch Pediatr Adolesc Med 2001;155:761-762.
FULL TEXT
|
